Home > M&A deals 2006 > Gilead Sciences, Inc. acquires Corus Pharma, Inc.
Add-on Acquistion · Life Science · August 2006

Gilead Sciences, Inc. acquires Corus Pharma, Inc.

On August 11, 2006, Gilead Sciences, Inc. acquired Corus Pharma, Inc., a life science company in Washington, United States.

Deal at a glance

AnnouncedAugust 11, 2006 TypeAdd-on Acquistion TargetCorus Pharma, Inc. Buyer Gilead Sciences, Inc. SectorLife Science LocationWashington, United States ValueMembers only

Target company

Corus Pharma, Inc.
Washington, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Gilead Sciences, Inc.
Company · 30 deals on record
  • 3rd transaction in life science
  • 3rd transaction in United States
30deals, all time
25in this sector
2026latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Tubulis GmbHSame lead buyer · Apr 2026
Ouro MedicinesSame lead buyer · Mar 2026
Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Corus Pharma, Inc.?Gilead Sciences, Inc. acquired Corus Pharma, Inc. on August 11, 2006.

What type of deal was it?It was a add-on acquistion in the life science sector in 2006.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).